Adherence Cancer Exercise Randomized clinical trial Treatment Background: Adherence has significantly affected the efficacy of a randomized clinical trial (RCT) to test exercise interventions. Objective: The aims of this study were to analyze exercise-related adherence patterns among patients receiving active cancer treatment and to identify factors related to exercise adherence and contamination in both the intervention and control groups. Methods: This is a secondary analysis of data from an RCT of a home-based walking intervention for patients receiving active cancer treatment. Hierarchical Poisson regression analysis was used to identify factors related to exercise adherence and exercise contamination in the exercise intervention and control groups. Results: A total of 126 patients finished the study. Exercise adherence rate in the intervention group was 32.35%, whereas exercise contamination rate in the control group was 12.07%. Independent predictors of adherence for the exercise group were baseline physical fitness, pretreatment fatigue level, treatment-related mood disturbance, and marital status (P G .01); exercise history significantly predicted exercise contamination (P G .00) in the control group. Conclusion: Adherence remains an issue in an exercise RCT among patients on active cancer treatment.
outcome variables in this study to reduce confounding effects. Oncology clinicians can use the study findings to appropriately tailor strategies to encourage exercise adherence among patients receiving active cancer treatment so that these patients can receive the known benefits of exercise.
n Background and Significance Cancer and cancer treatment are associated with unfavorable symptoms and a decline in physical function. 1, 2 Exercise has been proposed as a way to manage symptoms and improve physical function. Across an increasing number of exercise studies conducted with cancer populations, the randomized controlled trial (RCT) has been primarily used, because of its potential to test the effectiveness of exercise intervention. However, poor adherence within exercise and control groups can seriously counteract the effectiveness of exercise on outcome variables, potentially skewing the results of such RCTs. 3Y5 Adherence, generally understood as the level of participation achieved in a behavioral regimen once an individual has agreed to undertake it, 6 has alternate meanings in the case of exercise-related RCTs: In the intervention group when the participants are instructed to exercise, those who reached prescribed exercise levels are referred to as exercise adherents. However, among sedentary controls, those who remain inactive are referred to as control group adherents. Exercise engaged in by control group participants is then referred to as exercise contamination.
To effectively assess the efficacy of an exercise intervention in an RCT, a high level of adherence by each study group is desirable. Realistically, this presents a challenge. For example, Mock et al 5 reported that only 72% of breast cancer patients in a home-based exercise program achieved the minimum requirement of their exercise regimen in the intervention group, whereas 39% of the control group patients exercised. Similarly, Courneya et al 3 reported a 75.8% adherence rate in the intervention group and a 51.6% contamination rate in the control group among colorectal cancer survivors in a home-based exercise study. More specifically, in an RCT of home-based exercise program among cancer patients, from which this analysis is drawn, intent-to-treat analysis yielded no differences between the exercise group and control group on multiple outcomes of interest such as fatigue, and physical function, possibly because of issues encompassing adherence, 4 which warrants a further analysis on adherence in this sample.
Exercise adherence/contamination rates do not provide information regarding how exercise levels change over time. The long-term effects and accompanying benefits can be different for 2 patients with the same overall adherence rates but different exercise patterns. However, only very few investigators have explored adherence patterns in exercise RCT within cancer populations with conflicting results. Some investigators have reported a decline in adherence in the exercise intervention group, 7Y9 whereas others have found an increase in exercise adherence over time. 10, 11 No studies on exercise patterns in control group participants could be found.
Given the importance of adherence to appropriately evaluate exercise outcomes in RCTs, it is necessary to monitor and improve adherence in both the exercise intervention and control groups. A critical first step is to understand the determinants of exercise adherence and exercise contamination in RCTs. The few studies that have focused on this issue have produced conflicting results. In 1 study, researchers found no significant difference in age, smoking status, treatment type, physical activities, BMI, and psychosocial factors between exercise adherents and nonadherents among women 12 to 36 months after breast cancer treatment in a supervised exercise program 12 ; another group found that age, gender, employment status, cancer treatment type, exercise history, and some selected psychological factors were significantly related to exercise adherence in a supervised resistance training program involving cancer survivors. 13Y16 Whereas most researchers have focused on cancer survivors after their cancer treatment, a few investigators have studied the cancer patients on active cancer treatments. One researcher found that patients' baseline inactivity and days on chemotherapy related to decrease of exercise adherence, 17 two investigators have observed that cancer patients experiencing cancer and treatment-related symptoms often failed to follow their exercise prescription. 9, 18 However, the relationship between symptoms and exercise adherence was not statistically tested.
A few investigators have examined the determinants of exercise contamination in the control group. In a control group, men were more likely to exercise than women did, and exercise history was significantly and positively associated with exercise contamination. 14, 15 These findings were corroborated by another researcher who discovered that control group nonadherents had actively engaged in regular exercise before study enrollment. 9 Thus, adherence is a critical issue that can weaken the efficacy of RCTs in assessing the effects of exercise. Although a small number of investigators have previously addressed the adherence issue in RCTs involving cancer populations and have explored factors related to exercise adherence and contamination, several important gaps remain: (1) The literature lacks information regarding exercise patterns for both exercise and control groups over time. (2) Most studies have focused on cancer survivors after treatment, and few have examined patients receiving active cancer treatment who are likely to experience disease-and treatment-related symptoms that might affect exercise behavior.
To address these gaps and provide evidence for future exercise research, we examined adherence among RCTenrolled patients receiving active cancer treatment and looked at potential factors related to the exercise adherence and contamination among both the intervention and control groups.
n Methods
This study was a secondary analysis of data from an RCT designed to determine the effects of a home-based mild-tomoderate muscle strengthening and walking exercise program on the management of fatigue and other outcomes in cancer patients receiving either chemotherapy or radiation treatment. The study was approved by the Western Institutional Review Board. Data collection for the RCT began in October 2002 and ended in October 2006. In the parent study, 4 cancer patients from a university teaching hospital and a community cancer center were screened using the eligibility criteria: (1) 21 years or older, (2) newly diagnosed with stage 0, I, II, or III cancer, (3) scheduled to receive chemotherapy or radiation therapy as initial treatment, (4) no evidence of metastatic disease, (5) no concurrent health problems/disabilities that would limit their ability to participate, and (6) not currently exercising more than 3 times per week totaling 120 minutes. Eligible patient were contacted by the research staff. Those who agreed to participate in the study provided signed written consent, after which demographic information, baseline symptoms, and physical function capacity were assessed in interviews conducted by research staff. After enrollment, subjects were randomly assigned to either the control group or the exercise group.
Patients in the control group were instructed to continue their usual levels of physical activity, whereas patients in the exercise group were given an individualized exercise prescription after the initial assessment of physical status and fitness levels. The exercise prescription was a brisk 10-minute walk that increased to 30 minutes for 5 days per week as training progressed. The intensity of this walking prescription was to reach approximately 50% to 70% of maximum heart rate, consistent with the American College of Sports Medicine guidelines for ill populations. 19, 20 Participants were instructed to reach the desired goal of continuous exercise for 20 to 30 minutes each session; however, very deconditioned individuals were told to assume a slower pace of 2 sessions of 5 to10 minutes per day. Exercise participants were asked to wear pedometers daily throughout the study and to complete a daily exercise log. The control group participants also completed a daily exercise log but only wore pedometers for the first and last 2 weeks of the study period to prevent potential Hawthorne or measurement effects. The exercise log data for both groups were collected and returned at a weekly basis throughout the entire study period.
Participants in both groups were contacted through biweekly telephone calls by research nurses to discuss their physical activity, cancer treatment, side effects, and any concerns occurring in the previous 2 weeks. For the exercise group, adjustments to the walking prescription were made according to participants' condition. A telephone log was completed by study nurses after each telephone call.
For each participant, a midtreatment point was calculated when he/she was contacted by research nurses and assessed his/her symptoms in a previous month. In postYcancer treatment period, the participants were interviewed again by the research nurses when their symptoms for the previous month and physical function capacity were reassessed.
Measurement
Physical activity during the intervention phase was measured by a daily exercise log, an instrument developed specifically for the parent study. The exercise log was used in both exercise and control groups to measure exercise activity and fatigue level on a daily basis, and to compute the weekly exercise minutes and exercise sessions, is correlated to an objective measurement of exerciseVa pedometer. 21 Based on American College of Sports Medicine guidelines of 85% of minimum adherence to exercise prescription 20 and consistent with a similar exercise protocol found in the literature, 5 the individual week was defined as follows: first an adherent week for the exercise intervention group or a contaminated week for the control group occurred if the participant engaged in more than 60 minutes of aerobic activities and in more than 3 sessions in that week. Next, the individual adherence rate (or contamination rate) was then calculated as the percentage of adherent weeks (or contaminated weeks) out of the total prescribed weeks for each (adherent weeks/total prescribed weeks). Finally, the exercise adherents (or control group nonadherents) were defined as those participants who had an individual adherence rate (or individual contamination rate) greater than 67%. In other words, participants who adhere to group assignments for more than two-thirds of the entire study period were defined as group adherents.
Symptoms that were studied include fatigueVmeasured by Piper Fatigue Scale, 22 a 22-item, 10-point Likert-type selfreport scale with internal consistency reliabilities from 0.83 to 0.93; mood disturbance 23 Vmeasured by a 30-item self-report scale with a high subscales correlation (r = 0.951Y0.979); symptom distress 24 Vmeasured by a 14-item 5-point self-report scale often used in cancer population and with good validity and internal consistency reliability (0.79 and 0.89); and sleep disturbanceVmeasured by Pittsburgh Sleep Quality Index, 25 an 11-item instrument that assesses different aspects of sleep quality. In this adherence analysis, a single item from the Pittsburgh Sleep Quality Index was used to evaluate participants' overall sleep quality in past month. The physical function was measured by the physical function subscale in the well-established Medical Outcome Study 26 Short Form-36 and physical fitness. The physical fitness was measured by the treadmill test with maximal oxygen uptake 27 that was recorded by the highest observed value of VO2. For participants who could not do treadmill (for schedule difficulty with treadmill testing center), a 12-minute walking tested was offered and results were converted to VO2 max. 28 
Statistical Analysis
Descriptive statistics were used to report exercise adherence or contamination in both groups. Weekly exercise minutes and weekly exercise sessions, the individual adherence or contamination rate, and total number of exercise adherents (or control group nonadherents) were reported for both the exercise intervention and control groups. Exercise pattern was determined from the exercise logs. The weekly exercise minutes were calculated for each individual. Because of the participants' differing cancer treatment protocols, the total study duration varied by participants, ranging from 5 to 35 weeks. To capture exercise trends for patients with different study durations, the total duration was standardized by being converted to 10, with 0 representing the beginning of the study and 10 representing the end of the study.
Bivariate correlations were assessed between each independent variable and the outcome variables defined as the individual adherence (or contamination rate). Variables that significantly (P G .10) correlated with outcome variables were retained in the Hierarchical Poisson regression analyses and were entered in the following order: (1) physiological factors, (2) medical factors, and (3) sociodemographic factors. In this analysis, the individual adherence (contamination) rate was calculated as the number of adherent (or contaminated) weeks divided by the total number of weeks (exposure). The Poisson regression is appropriate for rate data in which the rate is a count of events (in this study, the number of adherent/contaminated weeks) divided by exposure (the number of total treatment weeks), because the outcome variables, the individual adherence (or contamination) rates, were between 0 and 1 and skewed. Finally, the effect size was calculated by using Cohen's f for each block of factors.
By using our daily exercise log, we further explored the relationship between exercise and fatigue on a weekly basis. We computed the weekly total exercise minutes and weekly average fatigue score and conducted linear regression models for the groups of exercise adherents, exercise nonadherents, control group adherents, and control group nonadherents.
n Results
Exercise Adherence and Contamination
A total of 138 patients were enrolled in the parent study. Twelve patients withdrew from the study for various reasons such as change in cancer treatment plan or medical complication, 4 leaving 126 patients who completed the study: 68 in the exercise group and 58 in the control group. Table 1 summarizes the characteristics of the sample and shows no significant differences between the groups, except that more participants in the control group than in the intervention group had completed graduate school (P = .041). Table 2 shows participants' symptoms and function capacity before and after cancer treatment. Participants reported minor symptoms and few limitations in physical function before cancer treatment. By the end of the treatment, participants reported slightly worsened symptoms and a decrease in function capacity. No significant differences were found for any of the pretreatment and posttreatment measures between the exercise and control groups.
In the exercise group, participants exercised an average (SD) of 4 (1.77) sessions and 113 (61.07) minutes/week. Nineteen participants (27.94%) adhered to the exercise assignments for the whole treatment period, and 3 participants (4.41%) did not adhere to the exercise prescription for any of the weeks in the entire treatment period. Using the cutoff point of 67% adherent weeks out of the total study weeks, 46 (67.65%) participants in the exercise group were exercise adherents, and 22 (32.35%) participants were exercise nonadherents. In the control group, participants exercised at an average (SD) of 1 (1.63) session and 48 (64.79) minutes/week. Four of 58 (6.89%) participants in the control group had engaged in more than 60 minutes of aerobic exercise and in more than 3 sessions weekly for the whole study period. Twenty-four (35.29%) participants had fully adhered to the group assignment, not exercising for the whole study period. Using the cutoff point of 67%, 51 (87.93%) control group participants were adherents, and 7 (12.07%) participants were nonadherents. Figure 1 shows how weekly exercise level changed over the study period for exercise adherents, exercise nonadherents, control group adherents, and control group nonadherents. The exercise adherents (n = 46) began with adequate exercise minutes (9120 minutes/week). Their weekly exercise minutes increased slightly (" = 2.72, P = .43) for about one-third of the study period and then gradually decreased (" = j3.74, P = .01), ending with an average of 115 minutes. The exercise nonadherents (n = 22) began with adequate exercise minutes (9100 minutes/week) but decreased their exercise level rapidly during the first half of the study (" = j14.51, P G .00) and maintained an average of less than 50 weekly exercise minutes for the remainder of the study period. The control group adherents (n = 51) followed their group assignment: They exercised less than 60 minutes/week over the entire study period and had slight changes in weekly exercise minutes throughout the whole study period. The control group nonadherents (n = 7) did not follow their group assignment. They began with a high level of exercise (about 170 minutes/week) and exercised more than 145 minutes/week for the entire study period, with little fluctuation from week to week. Table 3 shows the bivariate relationship between the outcome variableVindividual adherence (contamination) ratesVand each of the independent variables. The variables that were correlated (P G .10) with individual adherence rate in the exercise group were past physical activity (" = 0.22, P = .07), physical fitness (" = 0.19, P = .10), pretreatment fatigue level (" = j0.26, P = .03), midtreatment mood disturbance (" = j0.21, P = .09), cancer type (categorized as prostate cancer or nonprostate cancer) (t = j1.91, P = .06), and marital status (t = j2.30, P = .02). Variables that were related (P G .10) to 
Exercise Patterns

Bivariate Analysis
Hierarchical Poisson Regression Analysis
In the exercise group, physiological factors counted for 35% of variance in exercise adherence, medical factors for 39%, and sociodemographic factors for 1%. Thus, the final model (model 3 as shown in the Table 4 ) that included all 3 blocks of factors explained 75% of the variance in exercise adherence. The variables significantly associated with individual adherence rate in the final model were physical fitness (" = 0.51, P G .01), exercise history (" = 0.01, P G .01), pretreatment fatigue level (" = j0.93, P G .01), lower midtreatment mood disturbance (" = j0.27, P G .01), and being married (" = j3.56, P G .05). In the exercise intervention group, the medical factors had the largest effect size (f 2 = 1.50) on exercise adherence, followed by physiological factors, which had a large effect size (f 2 = 0.54). Sociodemographic factors had a small effect size (f 2 = 0.04; Table 4 ).
In the control group, physiological factors counted for 27% of the variance in exercise contamination. Medical factors added 10% and demographic factors 9%. Thus, the final model explained 46% of the variance in exercise contamination in this group. Exercise history (" = 0.01, P G .05), midtreatment symptom distress (" = j0.45, P G .01), and ethnicity (" = 4.47, P G .05) were significantly related to individual contamination rate. Physiological factors had a large effect size (f 2 = 0.37) on exercise contamination, as did medical factors, with a median effect size (f 2 = 0.16) and the demographic factors with a median effect size (f 2 = 0.17; Table 5 ). Relationship Between Weekly Fatigue Level and Weekly Exercise Minutes Figure 2 demonstrates how weekly exercise minutes changed with fatigue for the 4 groups. Exercise adherents were the only group of participants who maintained and even increased their exercise levels when experiencing increasing level of fatigue (" = 9.83, P = .01). Exercise nonadherents managed to increase their weekly exercise level when experiencing midlevel of fatigue (fatigue G 4; " = 10.04, P = .04). However, when experiencing a higher level fatigue (Q5), these participants dramatically reduced their exercise level (" = j11.78, P = .01). The control group adherents maintained a low level of exercise (G50 minutes/week) and did not change much with fatigue (" = j0.86, P = .45). The control group nonadherents had a decrease of exercise level when their fatigue level increased (" = j12.20, P = .01). The findings suggest that fatigue affected most cancer patients' exercise adherence. However, the continuous increase of exercise level among the exercise adherents implies that other factors (that are identified in the regression models as listed previously) play important roles in their exercise.
n Discussion
The present study examined the determinants of exercise adherence and contamination and their correlates among patients on active cancer treatment. Our findings are consistent with a home-based exercise program involving breast cancer patients on active cancer treatment exercise, 5 but it was on the low end of the exercise duration when compared to other studies 8, 10, 13, 29, 30 of cancer survivors, in which average weekly exercise times of 141 to 160 minutes and adherence rates of 67% to 97% were reported. The differences in exercise level may reflect differences in the respective study populations and study duration. These previous studies with higher adherence rates and more exercise minutes usually involved cancer survivors after treatment, who therefore had less severe symptoms and would be more likely to exercise when compared to patients such as ours who were concurrently undergoing cancer treatment. In contrast to our study, which had a duration of 5 to 35 weeks with a mean of 12.67 weeks, another study had a 5-week exercise program and reported a 97% adherence rate. 10 As the study's duration increased, exercise adherence decreased. 8 As compared to previous studies in which contamination rates were reported between 22% and 52%, 5, 13, 29, 31 our study had a lower contamination rate (12.07%), perhaps because we excluded those who had exercised more than 120 minutes/week on a regular basis before enrollment.
One novel contribution of our study is the identification of a strong relationship in the exercise group between exercise adherence and symptoms that included fatigue and mood disturbance. We studied patients on active cancer treatment, who often experience unpleasant symptoms that can affect their ability to exercise. Fatigue, the most often reported adverse effect experienced by cancer patients, has been commonly studied and fatigue level identified here and in a previous study 32 suggests that, in spite of evidence supporting the benefits of exercise over energy conservation, for some cancer patients, energy conservation continues to be used as a primary strategy for fatigue management. Yet fatigue and insufficient exercise can be a vicious cycle. When fatigued, patients exercise less; the less they exercise, the more likely they are to lose physical capacity and experience more fatigue. The strong relationship between exercise adherence and fatigue indicates that patient education is still necessary to promote exercise among cancer patients. Mood disturbance is another commonly reported symptom among cancer patients. For patients who are facing a lifethreatening illness and unpleasant symptoms related to cancer treatment, some level of mood distress is inevitable and can affect patients' participation in exercise. One researcher has reported a negative relationship between mood disturbance, especially depression, and cancer patients' participation in exercise in a non-RCT study. 33 In a series of qualitative interviewswith exercise nonadherents in our study, patients noted that treatment-related adverse effects such as fatigue, depression, and other medical symptoms prevented them from exercising at the prescribed level. 34 Our observation that, among exercise nonadherents, the number of weekly exercise minutes dropped sharply from more than 100 at the beginning to less than 50 minutes at the study midpoint indicates the importance of assessing patients for adverse effects after the first few doses of cancer treatment and evaluating how these adverse effects may affect their ability to exercise. In the case of patients experiencing severe symptoms, clinicians may need to increase the frequency of their contacts with patients, discuss strategies to effectively manage their symptoms, and either make exercise adjustments according to their specific medical condition or refer patients to a qualified health professional (ie, physical therapist or exercise physiologist).
Exercise history had an effect on both exercise adherence in the exercise group and exercise contamination in the control group, as has been observed in previous studies. 9, 15, 16 Exercise has the potential to improve bone remodeling and reduce the muscle weakness and wasting effects often caused by cancer treatment. It helps cancer patients maintain strength, endurance, and level of functioning 35 ; therefore, they are more likely to tolerate cancer treatment and subsequently to adhere to their exercise assignment even when experiencing severe unpleasant symptoms. With increasing evidence supporting the benefit of exercise among the general public and cancer patients, larger numbers of national and local media have highlighted the importance of exercise in health promotion. Meanwhile, oncology healthcare professionals have also been promoting exercise among cancer patients. Thus, it is not surprising that cancer patients begin to exercise and maintain their exercise practice as a habit. For participants in the exercise intervention group, the effect of habit helped them to maintain their exercise level. However, in the control group, habit may have explained why regular exercisers continued their preexisting level of exercise even after being assigned to a study control group.
Our analysis in subgroups (exercise adherent, exercise nonadherents, control adherents, and control nonadherents) reveals that exercise adherent and control nonadherents were able to maintain a sufficient level of exercise throughout the study (see Figure 1 ). However, when experiencing high levels of fatigue, only the exercise adherents managed to keep their exercise level, whereas control nonadherents reduced their exercise (see Figure 2) . This difference reflects the significant supporting role by healthcare professional in promoting exercise among cancer patients. During the study-prescribed biweekly telephone calls to the exercise group participants, the research nurses not only assessed their symptoms and readjusted their exercise assignments but also gave encouragement and support to the participants. Actually some patients indicated that it was the research nurses' telephone calls making them exercise. We also found that partnered participants were more likely to exercise than were nonpartnered counterparts, consistent with the important role played by family members in exercise adherence, as reported in 2 previous studies. 33, 36 During study enrollment, participants in the exercise intervention group in our study were encouraged to exercise with a family member to improve their adherence. Anecdotally, these patients reported that having a family member's encouragement was helpful, especially when they felt tired or depressed. Some patients also indicated that exercising in the company of family was entertaining and could address concerns about safety when exercising outside close to dark.
An additional new finding from our study was that white participants exercised more than did nonwhites in the control group, perhaps because of differences in access to exercise equipment or facilities. Although our exercise prescription was walking, some participants reported difficulty in exercising in bad weather. Therefore, access to exercise equipment or facilities could help them maintain exercise adherence. Socioeconomically disadvantaged adults have previously reported environmental barriers to physical activity. 37 However, information about access to exercise equipment and facilities was not captured in our study. This important disparity issue should be addressed in future research to ensure that minorities do not experience additional cancer disparities related to supportive management. It should be noted that the nature of the secondary analysis of data limited our ability to explore other factors of interest, such as the psychosocial factors and environmental factors that have been shown to have a significant impact on exercise adherence and contamination in previous studies. In the qualitative interviews with exercise nonadherents, some patients indicated environmental factors such as lack of access to exercise equipment or venue in the winter. 34 However, that information was not included in this data set and could not be included in analyses. Future studies should include both psychological and environmental factors related to exercise adherence. Second, the regression analyses combined patients with different types of treatment that make study duration vary. Separating groups by cancer treatments is limited because of the sample size. In addition, the cancer type and treatment type were found not significantly related to both exercise adherence and contamination. Finally, the generalizability of this study may be somewhat restricted because of the relative uniformity of the sample; participants in this study were primarily white, well-educated, and receiving treatment of prostate or breast cancer. Thus, we suggest replicating this work in a sample of cancer patients with more diverse ethnic backgrounds and lower levels of education to increase the applicability of the findings to other populations with cancer. n Implications for Research and Clinical Practice
In conclusion, our study has important implications for both research and clinical practice. The study contributes new knowledge about exercise for cancer patients among clinical healthcare providers who may better understand individual patient preferences for exercise during treatment and appreciate the difficulty that patients may have adhering to prescribed exercise regimens.
It is important for exercise RCT researchers to maintain a low contamination rate in the control group, in other words, to keep control group participants from exercising. Researchers can achieve this by excluding regular exercisers in the beginning. Or, if that exclusion is not an option, that the sample be stratified based on participants' previous exercise history. This approach may prove advantageous, even if an increase in the study sample size is required.
Based on our findings, healthcare professionals should help patients establish an exercise habit at an early stage in their diagnosis, suggest an individualized exercise plan based on their physical activity level, encourage family support, and assess and reassess their patients' conditions and exercise status throughout the treatment period and help patients adjust their exercise programs accordingly or refer patients to an appropriate exercise professional for further consultation. More specifically, the following strategies might be applied to improve exercise adherence: (1) assess the patient's baseline fatigue level and design an individual exercise prescription based on patient's situation;
(2) encourage the patient to identify a family member or a friend who can serve as an exercise partner to provide support or encouragement; encourage social support groups; (3) teach patients to exercise actively when the adverse effects and symptoms are at a minimum level; (4) establish regular contact with patients; (5) assess patients' situation and exercise condition, identify any problem that may serve as a barrier to keep patients from exercising, and adjust exercise according to patients' situation; and (6) engage patients in discussions surrounding symptoms such as fatigue and exercise.
